<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">182</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-4-127-130</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Non-canonical activity of retinoic acid in relation to the activation of protein kinases in transformed cells of different origin</article-title><trans-title-group xml:lang="ru"><trans-title>Неканоническая активность ретиноевой кислоты в отношении активации протеинкиназ в трансформированных клетках различного происхождения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7628-8616</contrib-id><name-alternatives><name xml:lang="en"><surname>Enikeev</surname><given-names>A. D.</given-names></name><name xml:lang="ru"><surname>Еникеев</surname><given-names>А. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0766-163X</contrib-id><name-alternatives><name xml:lang="en"><surname>Komelkov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Комельков</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7142-3316</contrib-id><name-alternatives><name xml:lang="en"><surname>Zborovskaya</surname><given-names>I. B.</given-names></name><name xml:lang="ru"><surname>Зборовская</surname><given-names>И. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6953-5244</contrib-id><name-alternatives><name xml:lang="en"><surname>Galetsky</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Галецкий</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4127-6973</contrib-id><name-alternatives><name xml:lang="en"><surname>Skryabin</surname><given-names>G. O.</given-names></name><name xml:lang="ru"><surname>Скрябин</surname><given-names>Г. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8837-7969</contrib-id><name-alternatives><name xml:lang="en"><surname>Tchevkina</surname><given-names>E. M.</given-names></name><name xml:lang="ru"><surname>Чевкина</surname><given-names>Е. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>Елена Максимовна Чевкина.</p><p>115478 Москва, Каширское шоссе, 24</p></bio><email>tchevkina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">НИИ канцерогенеза, ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина»  Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>127</fpage><lpage>130</lpage><history><date date-type="received" iso-8601-date="2019-01-04"><day>04</day><month>01</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-01-04"><day>04</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Enikeev A.D., Komelkov A.V., Zborovskaya I.B., Galetsky S.A., Skryabin G.O., Tchevkina E.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Еникеев А.Д., Комельков А.В., Зборовская И.Б., Галецкий С.А., Скрябин Г.О., Чевкина Е.М.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Enikeev A.D., Komelkov A.V., Zborovskaya I.B., Galetsky S.A., Skryabin G.O., Tchevkina E.M.</copyright-holder><copyright-holder xml:lang="ru">Еникеев А.Д., Комельков А.В., Зборовская И.Б., Галецкий С.А., Скрябин Г.О., Чевкина Е.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/182">https://umo.abvpress.ru/jour/article/view/182</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> The non-canonical activity of retinoic acid (RA) was discovered relatively recently and consists in the rapid activation of intracellular signaling pathways by the mechanisms not related to the transcriptional activity of the RA nuclear receptors. Separate data suggest that this activity can stimulate the processes of malignancy and contribute to the formation of tumor cell resistance to RA as a therapeutic agent. However, little is known about the mechanisms of this activity. It is also unclear how universal this effect is; does the RA-dependent activation of different signaling protein kinases occur in the same cells, and whether activation of these kinases is interrelated.</p><p><bold>Materials and methods</bold>: cultivation of non-small cell lung cancer cells and neuroblastoma cells under standard conditions and with incubation with all-trans retinoic acid (ATRA); immunoblotting.<bold/></p><p><bold>Results</bold>. Here we studied the effect of ATRA on the activation of Akt and Erk1/2 protein kinases depending on the incubation time. The analysis revealed RA-dependent activation of both kinases in all studied non-small cell lung cancer and neuroblastoma cell lines. Activation of Akt and Erk1/2 occurred at five minutes of incubation, which corresponds to the non-transcriptional (non-canonical) activity of the RA, however, further activation kinetics of the two kinases differed essentially.</p><p><bold>Conclusion.</bold> We found that ATRA causes rapid activation of Erk1/2 and Akt protein kinases in both non-small cell lung cancer and neuroblastoma cells. The differences in the kinetics of RA-dependent stimulation of these two kinases suggest that their activation is mediated by independent mechanisms.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>retinoic acid</kwd><kwd>non-canonical activity</kwd><kwd>protein kinase</kwd><kwd>phosphorylation</kwd><kwd>Erk1/2</kwd><kwd>Akt</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ретиноевая кислота</kwd><kwd>неканоническая активность</kwd><kwd>протеинкиназа</kwd><kwd>фосфорилирование</kwd><kwd>Erk1/2</kwd><kwd>Akt</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Russian Foundation for Basic Research, No. 16-04-01 559А</funding-statement><funding-statement xml:lang="ru">Российский фонд фундаментальных исследований, № 16-04-01 559А</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1.	Bushue N., Wan YJ.Y. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2.010;62(13):1285—98. DOI: 10.1016/j.addr.2010.07.003. PMID: 20654663.</mixed-citation><mixed-citation xml:lang="ru">Bushue N., Wan YJ.Y. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2.010;62(13):1285—98. DOI: 10.1016/j.addr.2010.07.003. PMID: 20654663.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2.	Connolly R.M., Nguyen N.K., Sukumar S. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res 2013;19(7):1651—9. DOI: 10.1158/1078-0432.CCR-12-3175. PMID: 23322901.</mixed-citation><mixed-citation xml:lang="ru">Connolly R.M., Nguyen N.K., Sukumar S. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res 2013;19(7):1651—9. DOI: 10.1158/1078-0432.CCR-12-3175. PMID: 23322901.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3.	Garattini E., Gianni M., Terao M. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr Pharm Des 2007;13(13):1375—400. PMID: 17506722. http://www.ncbi.nlm.nih.gov/pubmed/17506722.</mixed-citation><mixed-citation xml:lang="ru">Garattini E., Gianni M., Terao M. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr Pharm Des 2007;13(13):1375—400. PMID: 17506722. http://www.ncbi.nlm.nih.gov/pubmed/17506722.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4.	Soprano D.R., Qin P., Soprano K.J. Retinoic acid receptors and cancers. Annu Rev Nutr 2004;24:201-21. DOI: 10.1146/an-nurev.nutr.24.012003.132407. PMID: 15189119.</mixed-citation><mixed-citation xml:lang="ru">Soprano D.R., Qin P., Soprano K.J. Retinoic acid receptors and cancers. Annu Rev Nutr 2004;24:201-21. DOI: 10.1146/an-nurev.nutr.24.012003.132407. PMID: 15189119.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5.	Freemantle S.J., Spinella M.J., Dmitro-vsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003;22(47):7305—15. DOI: 10.1038/sj.onc.1206936. PMID: 14576840.</mixed-citation><mixed-citation xml:lang="ru">Freemantle S.J., Spinella M.J., Dmitro-vsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003;22(47):7305—15. DOI: 10.1038/sj.onc.1206936. PMID: 14576840.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6.	Persaud S.D., Lin Y.W., Wu C.Y. et al. Cellular retinoic acid binding protein I mediates rapid non-canonical activation of Erk1/2 by all-trans retinoic acid. Cell Signal 2013;25(1):19—25. DOI: 10.1016/j.cellsig.2012.09.002. PMID: 22982089.</mixed-citation><mixed-citation xml:lang="ru">Persaud S.D., Lin Y.W., Wu C.Y. et al. Cellular retinoic acid binding protein I mediates rapid non-canonical activation of Erk1/2 by all-trans retinoic acid. Cell Signal 2013;25(1):19—25. DOI: 10.1016/j.cellsig.2012.09.002. PMID: 22982089.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7.	Persaud S.D., Park S.W., Ishigami-Yuasa M. et al. All trans-retinoic acid analogs promote cancer cell apoptosis through nongenomic Crabp1 mediating Erk1/2 phosphorylation. Sci Rep 2016;6:22396. DOI: 10.1038/srep22396. PMID: 26935534.</mixed-citation><mixed-citation xml:lang="ru">Persaud S.D., Park S.W., Ishigami-Yuasa M. et al. All trans-retinoic acid analogs promote cancer cell apoptosis through nongenomic Crabp1 mediating Erk1/2 phosphorylation. Sci Rep 2016;6:22396. DOI: 10.1038/srep22396. PMID: 26935534.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8.	Quintero Barceinas R.S., Garcia-Regala-do A., Arechaga-Ocampo E. et al. All-trans retinoic acid induces proliferation, survival, and migration in A549 lung cancer cells by activating the Erk signaling pathway through a transcription-independent mechanism. Biomed Res Int 2015;2015:404368. DOI: 10.1155/2015/404368. PMID: 26557664.</mixed-citation><mixed-citation xml:lang="ru">Quintero Barceinas R.S., Garcia-Regala-do A., Arechaga-Ocampo E. et al. All-trans retinoic acid induces proliferation, survival, and migration in A549 lung cancer cells by activating the Erk signaling pathway through a transcription-independent mechanism. Biomed Res Int 2015;2015:404368. DOI: 10.1155/2015/404368. PMID: 26557664.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9.	Alsayed Y., Uddin S., Mahmud N. et al. Activation of Rac1 and the p38 mitogenactivated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 2001;276(6):4012—9. DOI: 10.1074/jbc.M007431200. PMID: 11060298.</mixed-citation><mixed-citation xml:lang="ru">Alsayed Y., Uddin S., Mahmud N. et al. Activation of Rac1 and the p38 mitogenactivated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 2001;276(6):4012—9. DOI: 10.1074/jbc.M007431200. PMID: 11060298.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10.	Masia S., Alvarez S., de Lera A.R. et al. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 2007;21(10):2391 —402. DOI: 10.1210/me.2007-0062. PMID: 17595318.</mixed-citation><mixed-citation xml:lang="ru">Masia S., Alvarez S., de Lera A.R. et al. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 2007;21(10):2391 —402. DOI: 10.1210/me.2007-0062. PMID: 17595318.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11.	Piskunov A., Rochette-Egly C. A retinoic acid receptor RARa pool present in membrane lipid rafts forms complexes with G protein aQ to activate p38MAPK. Oncogene 2012;31(28):3333—45. DOI: 10.1038/onc.2011.499. PMID: 22056876.</mixed-citation><mixed-citation xml:lang="ru">Piskunov A., Rochette-Egly C. A retinoic acid receptor RARa pool present in membrane lipid rafts forms complexes with G protein aQ to activate p38MAPK. Oncogene 2012;31(28):3333—45. DOI: 10.1038/onc.2011.499. PMID: 22056876.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12.	Garcia-Regalado A., Vargas M., Garcia-Carranca A. et al. Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells. Mol Cancer 2013;12:44. DOI: 10.1186/1476-4598-12-44. PMID: 23693014.</mixed-citation><mixed-citation xml:lang="ru">Garcia-Regalado A., Vargas M., Garcia-Carranca A. et al. Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells. Mol Cancer 2013;12:44. DOI: 10.1186/1476-4598-12-44. PMID: 23693014.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Bruck N., Vitoux D., Ferry C. et al. A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J 2009;28(1):34-47. DOI: 10.1038/emboj.2008.256. PMID: 19078967.</mixed-citation><mixed-citation xml:lang="ru">Bruck N., Vitoux D., Ferry C. et al. A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J 2009;28(1):34-47. DOI: 10.1038/emboj.2008.256. PMID: 19078967.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
